Valuation (43%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 7.62 | 5.35 |
| PEG Ratio (TTM) | -0.27 | -1.25 |
| P/S Ratio (TTM) | 5.90 | 50.25 |
| P/B Ratio (TTM) | 0.97 | 0.97 |
| P/FCF Ratio (TTM) | 5.24 | 19.86 |
| Price to 5YR AVG Earnings Ratio | N/A | 28.35 |
| Price to 5YR AVG FCF Ratio | N/A | 30.56 |
Profitability (60%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 10.85% | 1.20% |
| ROE (TTM) | 13.18% | 5.34% |
| Net Profit Margin (TTM) | 97.95% | 29.04% |
| ROIC 5YR AVG | N/A | 8.44% |
Growth (43%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -12.10% | 140.82% | N/A |
| Revenue | 6.31% | 180.29% | N/A |
| Net Income | 1.05% | 156.93% | N/A |
| Cash Flow | -7.11% | 1,961.81% | N/A |
Health (39%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.27 | 1.62 |
| Quick Ratio (TTM) | 0.27 | 1.58 |
| D/E Ratio (TTM) | 0.08 | 0.72 |
| Interest Coverage (TTM) | 30.15 | 21.29 |
| Piotroski F-Score | 7 | 6 |
| Altman Z-Score | 2.73 | 7.24 |
| LTL to 5YR AVG FCF | N/A | 9.60 |
| Shares Outstanding Growth 5YR AVG | N/A | -1.75% |